Search research articles
Contact Us
Filters
Showing results (171-180 of 199) with videos related to
Page
of 20
Sort By:
Patient Preference and Adherence
|
December 20, 2022
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Marina B Klein, Jim Young, David Ortiz-Paredes, et al.
Lancet (London, England)
|
February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial
Chloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.
Vaccine
|
July 2, 2025
COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada
Cassandra Freitas, Curtis L Cooper, Abigail E Kroch, et al.
The Journal of Infectious Diseases
|
February 16, 2010
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection
David A Cooper, Jayvant Heera, James Goodrich, et al.
Gastro Hep Advances
|
May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV
Felice Cinque, Michael Nudo, Sahar Saeed, et al.
AIDS Research and Human Retroviruses
|
August 3, 2019
Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging
Erin E Sundermann, Kristine M Erlandson, Caitlin N Pope, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2021
Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial
Ann N Burchell, Darrell H S Tan, Ramandip Grewal, et al.
BMJ Open
|
December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
Cecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
BMC Infectious Diseases
|
September 13, 2017
The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Guy Baril, et al.
Med (New York, N.Y.)
|
April 19, 2022
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
Arinjay Banerjee, Jocelyne Lew, Andrea Kroeker, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 199) with videos related to
Sort By:
Page
of 20
Patient Preference and Adherence
|
December 20, 2022
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Marina B Klein, Jim Young, David Ortiz-Paredes, et al.
Lancet (London, England)
|
February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial
Chloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.
Vaccine
|
July 2, 2025
COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada
Cassandra Freitas, Curtis L Cooper, Abigail E Kroch, et al.
The Journal of Infectious Diseases
|
February 16, 2010
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection
David A Cooper, Jayvant Heera, James Goodrich, et al.
Gastro Hep Advances
|
May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV
Felice Cinque, Michael Nudo, Sahar Saeed, et al.
AIDS Research and Human Retroviruses
|
August 3, 2019
Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging
Erin E Sundermann, Kristine M Erlandson, Caitlin N Pope, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2021
Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial
Ann N Burchell, Darrell H S Tan, Ramandip Grewal, et al.
BMJ Open
|
December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
Cecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
BMC Infectious Diseases
|
September 13, 2017
The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Guy Baril, et al.
Med (New York, N.Y.)
|
April 19, 2022
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
Arinjay Banerjee, Jocelyne Lew, Andrea Kroeker, et al.
Page
of 20